Tomika Crafter

FDA investigator

Appears on 4 documents from 2024 to 2025, mostly at sites in New Jersey. Most often cites sampling and testing of in-process materials and drug products (21 CFR 211.110(a)).

4
Documents on file
4.3
Observations per 483
2024
First seen
2025
Most recent

What they cite most

From 17 observations

Activity by year

2024: 2, 2025: 2

Where

New Jersey 2 · Georgia 1 · Tennessee 1

Is Tomika Crafter coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Dee Cee Laboratories, IncAug 11, 2025 · White House, Tennessee
483 Osmotica Pharmaceutical US LLCMay 2, 2025 · Marietta, Georgia
483 JC World BellNov 19, 2024 · Hackensack, New Jersey
483 Imprimis NJOF, LLCApr 3, 2024 · Ledgewood, New Jersey

About this profile

What does Tomika Crafter inspect?

Tomika Crafter appears on 4 documents on file covering 4 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.110(a) (sampling and testing of in-process materials and drug products), followed by 21 CFR 211.192 and 21 CFR 211.22(d).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Tomika Crafter is dated Aug 11, 2025.